logo

Sol-Gel Technologies Ltd. (SLGL)



Trade SLGL now with
  Date
  Headline
4/25/2022 7:31:32 AM Sol-Gel, Galderma Announce FDA Approval Of EPSOLAY For Inflammatory Lesions Of Rosacea
4/14/2022 8:45:42 AM Sol-Gel Technologies Announces Commercial Availability Of TWYNEO
12/21/2021 7:34:57 AM Sol-Gel: FDA Intends To Conduct Pre-approval Inspection Of Production Site For EPSOLAY During The Week Of Feb 14
6/28/2021 5:06:35 AM Sol-Gel And Galderma Announce Licenses For Commercialization Of EPSOLAY And TWYNEO In U.S.